Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 10:13:1049289.
doi: 10.3389/fphar.2022.1049289. eCollection 2022.

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

Muhammed Yunus Bektay  1   2 , Mesut Sancar  3 , Fatmanur Okyaltirik  4 , Bulent Durdu  5 , Fikret Vehbi Izzettin  1
Affiliations

Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

Muhammed Yunus Bektay et al. Front Pharmacol. .

Abstract

Objective: According to the World Health Organization (WHO), chest diseases are among the 10 diseases that cause the highest mortality worldwide. Drug-related problems (DRPs), readmission, and antimicrobial resistance are critical problems in chest disease wards. Active involvement of clinical pharmacists (CPs) who are focused on reducing the risks of potential problems is needed. The aim of this study is to investigate the effects of pharmaceutical care (PC) services on the pulmonology service. Method: A randomized controlled trial at a university hospital in Istanbul was conducted between June 2020 and December 2021. The participants were randomized into the control group (CG) and intervention group (IG). In the CG, CPs identified and classified the DRPs according to Pharmaceutical Care Network Europe v9.0 (PCNE) and provided solutions to DRPs for the IG. The effect of PC services was evaluated by the number and classification of DRPs, and readmissions within 30 days were compared between the two groups. Results: Out of 168 patients, 82 were assigned to the IG. The average number of medicines administered per patient in the CG and IG was 14.45 ± 7.59 and 15.5 ± 6.18, respectively. In the CG and IG, the numbers of patients with DRPs were 62 and 46, respectively. The total number of DRPs was 160 for CG and 76 for IG. A statistically significant difference was found in favor of the IG, in terms of the number of patients with DRPs, the total number of DRPs, and readmission within 30 days (p < 0.05). Conclusion: In this study, CP recommendations were highly accepted by the healthcare team. Pharmaceutical care services provided by CPs would decrease possible DRPs and led to positive therapeutic outcomes. Cognitive clinical pharmacy services have beneficial effects on health care, and these services should be expanded in all settings where patients and pharmacists are present.

Keywords: chest diseases; clinical pharmacist; cognitive pharmacy services; drug-related problems; pharmaceutical care.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Study flowchart.
FIGURE 2
FIGURE 2
Most used drugs and the number and percentage of patients using them.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. American College of Clinical Pharmacy Accp (2008). The definition of clinical pharmacy. Pharmacotherapy 28 (6), 816–817. 10.1592/phco.28.6.816 - DOI - PubMed
    1. Apikoglu-Rabus S., Yesilyaprak G., Izzettin F. V. (2016). Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir. Med. 120, 109–115. 10.1016/j.rmed.2016.10.006 - DOI - PubMed
    1. Ayhan Y. E., Karakurt S., Sancar M. (2022). The effect of the clinical pharmacist in minimizing drug-related problems and related costs in the intensive care unit in Turkey: A non-randomized controlled study. J. Clin. Pharm. Ther. 47 (11), 1867–1874. - PubMed
    1. Bekele F., Fekadu G., Bekele K., Dugassa D., Sori J. (2021). Drug-related problems among patients with infectious disease admitted to medical wards of Wollega University Referral Hospital: Prospective observational study. SAGE Open Med. 9, 2050312121989625. 10.1177/2050312121989625 - DOI - PMC - PubMed
    1. Bethesda (2012). LiverTox: Clinical and research information on drug-induced liver injury. Internet Available from: https://pubmed.ncbi.nlm.nih.gov/31643179/ . - PubMed